Wenjun Luo

Wenjun Luo is an associate in the Intellectual Property Practice Group in the firm's Shanghai office.

Areas of Practice

Wenjun’s practice focuses on intellectual property law, with a focus on technology transactions, patent prosecution, and IP litigation. She is experienced in handling cross-border technology transactions, where she navigates the complex area of pharmaceutical licensing covering both license-in and license-out deals. Her counsel is also sought after by clients in the high-tech sectors, where she offers strategic guidance on U.S. patent prosecution and patent portfolio management. Wenjun also assists clients in handling cross-border disputes, including litigating patent and trade secret cases before U.S. federal district courts and resolving contractual disputes before Hong Kong International Arbitration Centre (HKIAC).

Experience

• Assisted multiple Chinese pharmaceutical companies in cross-border pharmaceutical licensing transactions, including both license-in and license-out deals
• Assisted multiple Chinese semiconductor companies in reviewing IP-related agreements, including technology development and licensing agreements, supply agreements and non-disclosure agreements
• Assisted multiple Chinese semiconductor companies in prosecuting U.S. patents and managing their global patent portfolio, and counseled on noninfringement analysis and freedom-to-operate analysis
• Assisted a Chinese mobile data service provider in asserting patent infringement against its competitors in the North District of California, and successfully obtained a summary judgment confirming that the asserted patent is not invalid
• Assisted a Chinese smartphone original design manufacturer (ODM) in defending against patent infringement allegations brought by competitors in the Southern District of Florida, and successfully moved the court to dismiss all claims against the ODM due to plaintiff’s failure to serve through Hague
• Assisted a Chinese pharmaceutical company in resolving contractual disputes before Hong Kong International Arbitration Centre (HKIAC)

Articles

China Law Update Blog Posts

• "China’s Implementation of Patent Term Adjustment," September 13, 2024
• "China Proposed New Anti-Monopoly Guidelines for the Pharmaceutical Sector," August 27, 2024

• "Highlights of Revised Regulations for Implementing Patent Law of China," March 28, 2024

Global Trade Law Blog Posts

• "Potential Sanctions for Alleged Intellectual Property Theft on the Horizon?," January 19, 2023